Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

While research efforts have led to significant advances in recent years, particularly with respect to our understanding of MARV ecology and the development of treatment and vaccination options ...

Recent outbreaks have shown that MARV is capable of causing much more serious outbreaks than once thought. These large outbreaks not only had unprecedentedly high case–fatality rates but also ...

Object Details sova.sia.fa90-105_refidd1e30752 See more items in Records Records / Box 52 Container Box 52 of 69 Archival Repository Smithsonian Institution Archives ...

Epidemiology of Marburg Hemorrhagic Fever Outbreaks Marburg virus (MARV) forms its own genus within the family Filoviridae and, at present, only a single species – Lake Victoria marburgvirus – has ...

Other underlying conditions are solid organ transplantation, deferoxamine therapy, drug injections, renal failure, infant low birth weight, malnutrition, HIV infection, systemic lupus erythematosus, ...

In addition, TEMPO, lysosomal stabilizer mannose, and lysosomal iron chelator deferoxamine (DFO) inhibited sodium sulfite-induced ferroptosis. Overall, the results showed that sodium sulfite induced ...

Three-dimensional (3D)-printed scaffolds have been extensively researched in the field of tissue engineering for their exceptional biocompatibility as well as precise regenerative capabilities.

Deferoxamine mesylate is a chelating agent used in the treatment of iron overload in patients requiring regular transfusions. Deferoxamine is most commonly administered as a slow subcutaneous infusion ...

Explore open-access research on experimental pharmacology and drug discovery, including topics such as medicinal chemistry and physiological responses.